These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1322577)

  • 1. [Chromosomal restructurings and the distribution of chromosome fragile sites in the peripheral blood lymphocytes in a breast cancer patient after cytostatic therapy].
    Iakovleva TK; Monakhov AS; Moiseenko VM
    Tsitologiia; 1992; 34(2):77-83. PubMed ID: 1322577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common fragile sites: their prevalence in subjects with constitutional and acquired chromosomal instability.
    Tedeschi B; Porfirio B; Vernole P; Caporossi D; Dallapiccola B; Nicoletti B
    Am J Med Genet; 1987 Jun; 27(2):471-82. PubMed ID: 3111262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The determination of chromosome fragile sites in the peripheral blood lymphocytes of patients with colorectal cancer taking into account the cancer pathology predisposition in the familial anamnesis].
    Nesina IP; Polishchuk LZ; Oliĭnichenko PI
    Tsitol Genet; 2000; 34(1):3-9. PubMed ID: 10808535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosome fragile sites in patients with multiple primary tumors and familial forms of breast cancer].
    Kuleshov NP; Cortina-Guerrero GD; Razinkova GA; Gar'kavtseva RF; Nefedov MD; Kuzina NIu; Letiagin VP
    Vopr Onkol; 1992; 38(2):160-6. PubMed ID: 1300700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients.
    Dhillon VS; Husain SA; Ray GN
    Teratog Carcinog Mutagen; 2003; Suppl 1():35-45. PubMed ID: 12616595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal fragile site expression in dogs: I. Breed specific differences.
    Stone DM; Jacky PB; Hancock DD; Prieur DJ
    Am J Med Genet; 1991 Aug; 40(2):214-22. PubMed ID: 1910263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ablative hormone therapy and chemotherapy of metastatic breast cancer].
    Kasch R; Gerber B; Blaschke U
    Zentralbl Gynakol; 1989; 111(23):1584-7. PubMed ID: 2560303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fragile sites of cultured peripheral blood lymphocyte chromosomes in patients with gestational trophoblastic tumor].
    Xu C
    Zhonghua Fu Chan Ke Za Zhi; 1990 May; 25(3):159-61, 189. PubMed ID: 2167825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of folate sensitive and aphidicolin induced chromosomal fragile sites in familial neuroblastoma.
    Ankathil R; Kusumakumary P; Priyakumary T; Krishnan Nair M
    J Exp Clin Cancer Res; 2002 Sep; 21(3):383-8. PubMed ID: 12385582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous unusual expression of frequency of chromosome aberrations and common fragile in human lymphocytes of colorectal cancer patients induced by Aphidicolin.
    Saxena AK; Agarwal CS; Kumar M; Srivastava AK; Singh G
    J Exp Ther Oncol; 2007; 6(2):175-9. PubMed ID: 17407975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the genotoxicity of atenolol in human peripheral blood lymphocytes: correlation between chromosomal fragility and content of micronuclei.
    Télez M; Ortiz-Lastra E; Gonzalez AJ; Flores P; Huerta I; Ramírez JM; Barasoain M; Criado B; Arrieta I
    Mutat Res; 2010 Jan; 695(1-2):46-54. PubMed ID: 19932191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative intensive chemotherapy of operable breast cancer].
    Zhang B
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):228-30. PubMed ID: 2558871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer.
    Markiewicz DA; Fox KR; Schultz DJ; Harris EE; Haas JA; Glick JH; Solin LJ
    Cancer J Sci Am; 1998; 4(3):185-93. PubMed ID: 9612601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12q13 fragility in a family with recurrent spontaneous abortions: expression of the fragile site under different culture conditions.
    Giardino D; Bettio D; Simoni G
    Ann Genet; 1990; 33(2):88-91. PubMed ID: 2241090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Haffty B; Taylor M; McCormick B; McNeese M; Pierce LJ; Landmann C; Olivotto IA; Borger J; de La Rochefordiere A; Schultz DJ
    Cancer; 2001 Mar; 91(6):1090-7. PubMed ID: 11267953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Karyotypic anomalies and chromosomal sites of increased fragility in colorectal cancer].
    Sokova OI; Kirichenko OP; Kulagina OE; Konstantinova LN; Chebotarev AN; Fleĭshman EV
    Genetika; 1997 Sep; 33(9):1297-302. PubMed ID: 9445823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
    Wang ZY
    Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.